IGFBP2 Mediates Human iPSC-Cardiomyocyte Proliferation in a Cellular Contact-Dependent Manner

Soah Lee1,2,3, Paul Heinrich1,4,5, Daniel Lee1

  • 1Stanford Cardiovascular Institute (S.L., P.H., D.L., W.R.G., D.T.P., F.X.G., N.B., S.M.W.), Stanford University School of Medicine, CA.

Circulation Research
|October 1, 2025
PubMed
Abstract

Insights

Cell-cell contact suppresses cardiomyocyte proliferation by inhibiting IGFBP2 secretion. Supplementing IGFBP2 overcomes this inhibition, enabling 3D cardiac tissue growth for myocardial regeneration.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Cardiomyocyte proliferation is crucial for myocardial regeneration after injury.
  • Intrinsic inhibitory mechanisms in cardiomyocytes limit their expansion.
  • Cell-cell contact is hypothesized as a key suppressor of cardiomyocyte proliferation.

Purpose of the Study:

  • To investigate the role of cell-cell contact in suppressing cardiomyocyte proliferation.
  • To identify molecular pathways involved in this suppression.
  • To enable sustained cardiomyocyte proliferation in 3D contexts.

Main Methods:

  • Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were cultured at varying densities.
  • Phosphoproteomic profiling was used to identify signaling alterations.
  • Conditioned media were analyzed for secreted growth factors.

Main Results:

  • hiPSC-CM proliferation decreased with increased cell-cell contact, linked to adherens junction and sarcomere assembly.
  • Cell contact reduced beta-catenin nuclear translocation and TCF/LEF activity.
  • IGFBP2 enrichment in sparse cultures was identified as a pro-proliferative factor.

Conclusions:

  • Cell-cell contact inhibits hiPSC-CM proliferation via adherens junctions, sarcomeric assembly, and reduced IGFBP2 secretion.
  • Exogenous IGFBP2 can overcome contact inhibition, promoting 3D cardiac tissue growth.
  • Findings advance cardiac tissue engineering and regenerative therapies.